You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
華潤三九(000999.SZ):將以更進取的態度努力推動感冒藥業務發展
格隆匯 05-08 18:22

格隆匯5月8日丨華潤三九(000999.SZ)於2023年5月4日召開業績電話會,問答環節中,就“感冒藥的展望?關於感冒藥品類,是以感冒靈為主還是可能今年會多出一些咳嗽藥?”,公司回覆稱,去年感冒藥達到了一個較高的平台,因此公司在今年的規劃中追求穩健增長。從一季度的表現來看,感冒藥業務受甲流高發等影響,實現了較快增長。結合這一趨勢,公司將以更進取的態度努力推動感冒藥業務發展。

感冒藥品類發展方面,將繼續以感冒靈為核心,同時關注抗病毒口服液、止咳藥和中藥消炎藥等其他品種的發展。此外,公司還將感冒品類與大健康領域的維生素C等產品結合,因為越來越多的年輕人和消費者在經歷過去三年的變化後,意識到每個人都是自己健康的第一責任人。除了治療需求外,預防方面的需求也在增長,如維生素C和多維類產品。因此,公司在大健康產品方面也進行了一定的拓展。希望通過公司的努力,感冒藥品類在今年能實現較好的增長。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account